4//SEC Filing
AYCARDI-FONSECA ERNESTO 4
Accession 0001171843-18-002118
CIK 0001582313other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:44 PM ET
Size
5.3 KB
Accession
0001171843-18-002118
Insider Transaction Report
Form 4
AYCARDI-FONSECA ERNESTO
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-03-19+50,000→ 50,000 totalExercise: $4.65Exp: 2028-03-18→ Common Shares (50,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on March 19, 2019, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001734218
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 4:44 PM ET
- Size
- 5.3 KB